These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27398014)

  • 1. Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation.
    Singal A; Daulatabad D; Pandhi D; Arora VK
    J Cutan Aesthet Surg; 2016; 9(2):122-5. PubMed ID: 27398014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigmented basal cell carcinoma successfully treated with 5% Imiquimod cream.
    Mehta V; Balachandran C
    Indian J Dermatol; 2008; 53(3):140-1. PubMed ID: 19882014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream.
    Plachouri KM; Balasis S; Mallioris AF; Koumoundourou D; Georgiou S
    Dermatol Ther; 2018 Sep; 31(5):e12685. PubMed ID: 30133929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
    Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
    Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined effect of CO
    El-Khalawany M; Saudi WM; Ahmed E; Mosbeh A; Sameh A; Rageh MA
    J Cosmet Dermatol; 2022 May; 21(5):2049-2055. PubMed ID: 34333841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of facial superficial basal cell carcinomas with imiquimod 5% cream.
    Mirza B; De'Ambrosis B
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():16-8. PubMed ID: 14616806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
    Peris K; Campione E; Micantonio T; Marulli GC; Fargnoli MC; Chimenti S
    Dermatol Surg; 2005 Mar; 31(3):318-23. PubMed ID: 15841634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
    Vidal D; Matías-Guiu X; Alomar A
    Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermoscopy Patterns and Histopathological Findings in Nodular Basal Cell Carcinoma-Study on 68 Cases.
    Enache AO; Pătrașcu V; Simionescu CE; Ciurea RN; Văduva A; Stoica LE
    Curr Health Sci J; 2019; 45(1):116-122. PubMed ID: 31297272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.
    Huber A; Huber JD; Skinner RB; Kuwahara RT; Haque R; Amonette RA
    Dermatol Surg; 2004 Mar; 30(3):429-30. PubMed ID: 15008876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens.
    Shumack S; Robinson J; Kossard S; Golitz L; Greenway H; Schroeter A; Andres K; Amies M; Owens M
    Arch Dermatol; 2002 Sep; 138(9):1165-71. PubMed ID: 12224977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
    Bostanci S; Kocyigit P; Vural S; Heper AO; Botsali A
    Dermatol Surg; 2018 Jan; 44(1):36-41. PubMed ID: 29016542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin.
    Giannotti B; Vanzi L; Difonzo EM; Pimpinelli N
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():33-5. PubMed ID: 14616811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatoscopy-guided therapy of pigmented basal cell carcinoma with imiquimod.
    Husein-ElAhmed H; Fernandez-Pugnaire MA
    An Bras Dermatol; 2016; 91(6):764-769. PubMed ID: 28099598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream.
    Cowen E; Mercurio MG; Gaspari AA
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S240-8. PubMed ID: 12271286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature.
    Drehs MM; Cook-Bolden F; Tanzi EL; Weinberg JM
    Dermatol Surg; 2002 May; 28(5):427-9. PubMed ID: 12030878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
    Love WE; Bernhard JD; Bordeaux JS
    Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study.
    Butler DF; Parekh PK; Lenis A
    Dermatol Surg; 2009 Jan; 35(1):24-9. PubMed ID: 19018814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle.
    Berman B; Sullivan T; De Araujo T; Nadji M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():59-61. PubMed ID: 14616354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.